WALLACE, ELI,YANG, HONG WOON,LYSSIKATOS, JOSEPH P.
申请号：
CA2545659
公开号：
CA2545659C
申请日:
2004.11.18
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
Disclosed are compounds of the Formula (I) and pharmaceutically acceptablesalts and prodrugs thereof, wherein R1, R2, R7, R8, R9, R10, R20, R21,and R22are as defined in the specification. Such compounds are MFK inhibitors anduseful in the treatment of hyperproliferative diseases, such as cancer andinflammation, in mammals, and inflammatory conditions. Also disclosed aremethods of using such compounds in the treatment of hyperproliferativediseases in mammals and pharmaceutical compositions containing such compounds.
